Park, J., & Cheon, J. H. (2017). Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? Intest Res.
Citação norma ChicagoPark, Jihye, and Jae Hee Cheon. "Could Adalimumab Be Used Safely and Effectively in Intestinal Behçet's Disease Refractory to Conventional Therapy?" Intest Res 2017.
Citação norma MLAPark, Jihye, and Jae Hee Cheon. "Could Adalimumab Be Used Safely and Effectively in Intestinal Behçet's Disease Refractory to Conventional Therapy?" Intest Res 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.